F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Non-alcoholic steatohepatitis

Page 1 of 3 ( 143 items )
<<
1
2
3
>>

1	Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease 12/19/2025 10:39:41 AM \| Browse: 20 \| Download: 84
2	Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia 9/18/2025 9:55:58 AM \| Browse: 421 \| Download: 234
3	Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review 9/4/2025 7:48:05 AM \| Browse: 394 \| Download: 140
4	Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis 6/20/2025 7:30:13 AM \| Browse: 52 \| Download: 257
5	Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease? 5/26/2025 9:15:10 AM \| Browse: 94 \| Download: 401
6	Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities 2/24/2025 5:39:17 AM \| Browse: 117 \| Download: 516
7	Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States 2/21/2025 10:12:51 AM \| Browse: 125 \| Download: 432
8	Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study 2/18/2025 9:00:42 AM \| Browse: 117 \| Download: 647
9	Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease 11/26/2024 7:20:28 AM \| Browse: 148 \| Download: 522
10	Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrin αvβ3 expression with a targeted molecular imaging modality 11/6/2024 9:51:01 AM \| Browse: 104 \| Download: 683
11	Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential 9/23/2024 10:30:40 AM \| Browse: 187 \| Download: 651
12	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 182 \| Download: 531
13	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 158 \| Download: 558
14	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 216 \| Download: 675
15	Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease 5/22/2024 11:33:24 AM \| Browse: 214 \| Download: 661
16	Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 95 \| Download: 436
17	Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study 5/10/2024 11:51:40 AM \| Browse: 132 \| Download: 865
18	Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we? 4/12/2024 4:45:44 PM \| Browse: 134 \| Download: 622
19	Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity 1/26/2024 7:56:29 AM \| Browse: 376 \| Download: 1274
20	Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis 12/19/2023 2:09:20 AM \| Browse: 413 \| Download: 1012
21	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 350 \| Download: 1331
22	Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review 8/22/2023 7:39:26 AM \| Browse: 375 \| Download: 1160
23	Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk 8/2/2023 9:29:03 AM \| Browse: 320 \| Download: 1274
24	Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review 7/21/2023 9:10:50 AM \| Browse: 406 \| Download: 1418
25	Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted 6/25/2023 2:17:08 PM \| Browse: 237 \| Download: 953
26	Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index 6/16/2023 9:52:18 AM \| Browse: 402 \| Download: 1449
27	Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease 1/12/2023 10:19:09 AM \| Browse: 302 \| Download: 1035
28	Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? 1/6/2023 2:52:58 AM \| Browse: 310 \| Download: 704
29	Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver 9/23/2022 10:13:16 AM \| Browse: 578 \| Download: 1535
30	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 604 \| Download: 1253
31	Therapies for non-alcoholic fatty liver disease: A 2022 update 9/23/2022 12:48:56 AM \| Browse: 637 \| Download: 1467
32	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 555 \| Download: 1268
33	Transcriptome changes in stages of non-alcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 620 \| Download: 1308
34	Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis 7/27/2022 1:17:37 PM \| Browse: 570 \| Download: 1227
35	Minireview: Mechanisms of ductular reaction in non-alcoholic steatohepatitis 5/17/2022 12:57:55 PM \| Browse: 584 \| Download: 1146
36	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 676 \| Download: 1304
37	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 643 \| Download: 1583
38	Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis 4/22/2022 10:52:23 AM \| Browse: 718 \| Download: 2273
39	Is there a role of lipid-lowering therapies in the management of fatty liver disease? 1/21/2022 8:16:14 AM \| Browse: 545 \| Download: 1226
40	Abnormal liver enzymes: A review for clinicians 11/24/2021 9:54:22 AM \| Browse: 628 \| Download: 1188
41	Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study 11/19/2021 11:15:33 AM \| Browse: 751 \| Download: 1774
42	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 676 \| Download: 1161
43	Hepatocellular carcinoma in non-alcoholic fatty liver disease: A growing challenge 9/22/2021 8:09:41 AM \| Browse: 772 \| Download: 1517
44	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 823 \| Download: 1457
45	Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease 5/20/2021 3:14:20 PM \| Browse: 703 \| Download: 1954
46	Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration 4/28/2021 12:31:49 PM \| Browse: 916 \| Download: 1565
47	Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population 3/12/2021 9:59:35 AM \| Browse: 923 \| Download: 1908
48	Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? 2/25/2021 3:45:30 PM \| Browse: 819 \| Download: 2127
49	Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort 2/20/2021 2:51:13 AM \| Browse: 733 \| Download: 2026
50	Experimental models of metabolic and alcoholic fatty liver disease 12/30/2020 1:59:10 PM \| Browse: 1010 \| Download: 1810

Page 1 of 3 ( 143 items )
<<
1
2
3
>>

1	Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease 12/19/2025 10:39:41 AM \| Browse: 20 \| Download: 84
2	Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia 9/18/2025 9:55:58 AM \| Browse: 421 \| Download: 234
3	Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review 9/4/2025 7:48:05 AM \| Browse: 394 \| Download: 140
4	Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis 6/20/2025 7:30:13 AM \| Browse: 52 \| Download: 257
5	Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease? 5/26/2025 9:15:10 AM \| Browse: 94 \| Download: 401
6	Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities 2/24/2025 5:39:17 AM \| Browse: 117 \| Download: 516
7	Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States 2/21/2025 10:12:51 AM \| Browse: 125 \| Download: 432
8	Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study 2/18/2025 9:00:42 AM \| Browse: 117 \| Download: 647
9	Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease 11/26/2024 7:20:28 AM \| Browse: 148 \| Download: 522
10	Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrin αvβ3 expression with a targeted molecular imaging modality 11/6/2024 9:51:01 AM \| Browse: 104 \| Download: 683
11	Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential 9/23/2024 10:30:40 AM \| Browse: 187 \| Download: 651
12	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 182 \| Download: 531
13	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 158 \| Download: 558
14	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 216 \| Download: 675
15	Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease 5/22/2024 11:33:24 AM \| Browse: 214 \| Download: 661
16	Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 95 \| Download: 436
17	Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study 5/10/2024 11:51:40 AM \| Browse: 132 \| Download: 865
18	Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we? 4/12/2024 4:45:44 PM \| Browse: 134 \| Download: 622
19	Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity 1/26/2024 7:56:29 AM \| Browse: 376 \| Download: 1274
20	Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis 12/19/2023 2:09:20 AM \| Browse: 413 \| Download: 1012
21	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 350 \| Download: 1331
22	Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review 8/22/2023 7:39:26 AM \| Browse: 375 \| Download: 1160
23	Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk 8/2/2023 9:29:03 AM \| Browse: 320 \| Download: 1274
24	Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review 7/21/2023 9:10:50 AM \| Browse: 406 \| Download: 1418
25	Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted 6/25/2023 2:17:08 PM \| Browse: 237 \| Download: 953
26	Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index 6/16/2023 9:52:18 AM \| Browse: 402 \| Download: 1449
27	Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease 1/12/2023 10:19:09 AM \| Browse: 302 \| Download: 1035
28	Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? 1/6/2023 2:52:58 AM \| Browse: 310 \| Download: 704
29	Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver 9/23/2022 10:13:16 AM \| Browse: 578 \| Download: 1535
30	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 604 \| Download: 1253
31	Therapies for non-alcoholic fatty liver disease: A 2022 update 9/23/2022 12:48:56 AM \| Browse: 637 \| Download: 1467
32	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 555 \| Download: 1268
33	Transcriptome changes in stages of non-alcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 620 \| Download: 1308
34	Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis 7/27/2022 1:17:37 PM \| Browse: 570 \| Download: 1227
35	Minireview: Mechanisms of ductular reaction in non-alcoholic steatohepatitis 5/17/2022 12:57:55 PM \| Browse: 584 \| Download: 1146
36	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 676 \| Download: 1304
37	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 643 \| Download: 1583
38	Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis 4/22/2022 10:52:23 AM \| Browse: 718 \| Download: 2273
39	Is there a role of lipid-lowering therapies in the management of fatty liver disease? 1/21/2022 8:16:14 AM \| Browse: 545 \| Download: 1226
40	Abnormal liver enzymes: A review for clinicians 11/24/2021 9:54:22 AM \| Browse: 628 \| Download: 1188
41	Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study 11/19/2021 11:15:33 AM \| Browse: 751 \| Download: 1774
42	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 676 \| Download: 1161
43	Hepatocellular carcinoma in non-alcoholic fatty liver disease: A growing challenge 9/22/2021 8:09:41 AM \| Browse: 772 \| Download: 1517
44	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 823 \| Download: 1457
45	Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease 5/20/2021 3:14:20 PM \| Browse: 703 \| Download: 1954
46	Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration 4/28/2021 12:31:49 PM \| Browse: 916 \| Download: 1565
47	Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population 3/12/2021 9:59:35 AM \| Browse: 923 \| Download: 1908
48	Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? 2/25/2021 3:45:30 PM \| Browse: 819 \| Download: 2127
49	Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort 2/20/2021 2:51:13 AM \| Browse: 733 \| Download: 2026
50	Experimental models of metabolic and alcoholic fatty liver disease 12/30/2020 1:59:10 PM \| Browse: 1010 \| Download: 1810